HCC patients with SIRT4 expression >61.14 RPKM exhibited better survival than patients with low expression (<61.14 RPKM) of SIRT4 (Log-rank p = 0.041) (Fig. 2D). This evidence concerns the gene SIRT4 and hepatocellular carcinoma.